ATN ASTROCYTES TO NEURONS
Live / Registered — Registered (as of 18 Nov 2025)
What this means for you
Registered since 18 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97227503
- Registration number
- 8033032
- Mark type
- Stylized text
- Filed
- 19 Jan 2022
- Published for opposition
- 14 Feb 2023
- Registered
- 18 Nov 2025
- Attorney of record
- Lawrence M. Green
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), Huntington's disease, epilepsy, physical injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, infection, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic or hemorrhagic myelopathy (myelopathy), global ischemia, hypoxic ischemic encephalopathy, embolism, fibrocartilage embolism myelopathy, thrombosis, nephropathy, chronic inflammatory disease, meningitis, cerebral venous sinus thrombosis, retinal disease and other disease arising from neuronal damage; and testing, inspection, research or development of pharmaceutical preparations for gene therapy or small molecule treatment
Owner
- NeuExcell Therapeutics Inc., Philadelphia, PA, US
- NeuExcell Therapeutics Inc., Philadelphia, PA, US
- NeuExcell Therapeutics Inc., Philadelphia, PA, US
Prosecution history
- 18 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 30 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Apr 2025 — USE AMENDMENT FILED
- 23 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Apr 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Apr 2025 — SOU EXTENSION 4 GRANTED
- 07 Apr 2025 — SOU EXTENSION 4 FILED
- 07 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Aug 2024 — SOU EXTENSION 3 GRANTED
- 28 Aug 2024 — SOU EXTENSION 3 FILED